|drug1104||Crest Pro-Health Multi-Protection mouthwash Wiki||1.00|
|drug1247||Distilled water Wiki||1.00|
|drug2147||Listerine Mouthwash Product Wiki||1.00|
|D010608||Pharyngeal Diseases NIH||1.00|
|D014777||Virus Diseases NIH||0.11|
|D045169||Severe Acute Respiratory Syndrome NIH||0.04|
There is one clinical trial.
Patients who are severely ill with COVID-19 may benefit from receiving plasma infusions from donors who have recovered from the disease and are proven to no longer be infected. Efforts to initiate the collection and infusion of these products to high risk patients have been initiated around the world and the FDA has recently provided information about how this could be accomplished. As the Jefferson Blood Donor Center already has processes to collect, test and process blood, investigators are planning to make efforts to collect plasma for this use should it be necessary. The purpose of this study is to describe the process for identifying and collecting convalescent plasma from donors previously infected with the virus. The research portion on top of this standard blood product collection will the process of identification of subjects and processes by which blood products are processed in this special population. This protocol does not involve the administration of blood products to patients with COVID-19 infection.
Description: # of individuals screened eligibleMeasure: Number of patients who screen eligible for donation Time: 1 year
Description: # of patients who consent to donationMeasure: Number of patients who consent to plasma donation Time: 1 year
Description: # of plasma donations receivedMeasure: Number of plasma donations received Time: 1 year
Description: Side effects or adverse events related to plasma donationMeasure: Safety of donation procedures Time: 1 year
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports